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Mitochondrial ribosomes translate membrane inte-
gral core subunits of the oxidative phosphorylation
system encoded by mtDNA. These translation prod-
ucts associate with nuclear-encoded, imported pro-
teins to form enzyme complexes that produce ATP.
Here, we show that human mitochondrial ribosomes
display translational plasticity to cope with the sup-
ply of imported nuclear-encoded subunits. Ribo-
somes expressing mitochondrial-encoded COX1
mRNA selectively engagewith cytochrome c oxidase
assembly factors in the inner membrane. Assembly
defects of the cytochrome c oxidase arrest mito-
chondrial translation in a ribosome nascent chain
complex with a partially membrane-inserted COX1
translation product. This complex represents a
primed state of the translation product that can be
retrieved for assembly. These findings establish a
mammalian translational plasticity pathway in mito-
chondria that enables adaptation of mitochondrial
protein synthesis to the influx of nuclear-encoded
subunits.
INTRODUCTION
Mitochondria play a vital role in cellular energy production and
intermediate metabolism. Consequently, defects in mitochon-
drial function cause severe disorders in human and initiate
cellular stress response and signaling pathways that alter nu-
clear gene expression (Chandel, 2015; Raimundo, 2014; Shadel
and Horvath, 2015). Among such mitochondrial malfunctions,
oxidative phosphorylation (OXPHOS) disorders define a group
of defects of the respiratory chain and the F1Fo ATP-synthase
causing severe and frequently fatal neuromuscular or cardiac
disorders (Antozzi and Zeviani, 1997; DiMauro and Schon,
2003; Smeitink et al., 2006). The 13 core subunits of the
OXPHOS complexes I, III, IV, and V, all of which are integral
membrane proteins, are encoded by the mtDNA. Therefore,
one quarter of the mitochondrial proteome is dedicated to theCell 167, 471–483, Oc
This is an open access article under the CC BY-Nexpression and inheritance of mtDNA (Meisinger et al., 2008).
Besides the core subunits of the oxidative phosphorylation sys-
tem, the human mitochondrial genome encodes 2 rRNAs and 22
tRNAs, required for their translation (Ha¨llberg and Larsson,
2014). Accordingly, mitochondrial ribosomes are devoted to
the synthesis of membrane proteins for which they associate
to the inner membrane. The membrane inserted mitochondrial
translation products associate with nuclear-encoded subunits
in a defined order, eventually forming stoichiometric, functional
enzyme complexes (Ferna´ndez-Vizarra et al., 2009; Richter-
Dennerlein et al., 2015; Soto et al., 2012). Obviously, this as-
sembly process requires that the products of two independent
genetic systems have to be carefully balanced against each
other to avoid an accumulation of idle subunits in the inner
membrane. In case of cytosolic proteins, the synthesis of com-
ponents of multiprotein complexes has been shown to be
balanced through translational or transcriptional control mecha-
nisms, so that subunits are synthesized in proportion to their
stoichiometry (Li et al., 2014). However, in contrast to nuclear
gene expression processes, we lack insight into how gene
expression and especially mitochondrial translation is regulated
in metazoa.
With regard to the assembly of respiratory chain complexes,
the cytochrome c oxidase (complex IV) has been best analyzed.
A plethora of chaperone-like factors, termed assembly factors,
participate in formation and stabilization of transient inter-
mediates in the biogenesis process. The assembly process
commences with the synthesis of the mitochondrial-encoded
COX1 that serves as a headstone on which the complex is built.
Newly synthesized and membrane integrated COX1 engages
with the assembly factors C12ORF62 (hCOX14) and MITRAC12
(hCOA3), forming assembly intermediates termed MITRAC
(Clemente et al., 2013; Dennerlein et al., 2015; Mick et al.,
2012; Ostergaard et al., 2015; Weraarpachai et al., 2012).
Loss of C12ORF62 or MITRAC12 leads to complex IV-defi-
ciency and concomitantly neuromuscular disorders (Ostergaard
et al., 2015; Weraarpachai et al., 2012). The lack of C12ORF62
or MITRAC12 has been found to affect COX1 synthesis, sug-
gesting that these proteins may link complex IV assembly to
translational performance of mitochondrial ribosomes in an
undefined manner (Clemente et al., 2013; Mick et al., 2012;
Szklarczyk et al., 2012; Weraarpachai et al., 2012). This findingtober 6, 2016 ª 2016 The Author(s). Published by Elsevier Inc. 471
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. C12ORF62 Interacts with Trans-
lating Mitochondrial Ribosomes
(A) [35S]methionine-labeled mitochondrial trans-
lation products were subjected to immunoprecip-
itation with indicated antibodies. Total, 5%; elu-
ates, 100%.
(B) Equal amounts of isolated mitochondria from
differentially SILAC-labeled HEK293T wild-type
cells or cells expressing C12ORF62FLAG were
subjected to FLAG-immunoisolation. Purified
protein complexes were natively eluted and
analyzed by liquid chromatography-mass spec-
trometry (LC-MS) (n = 4). Thresholds: p < 0.05;
mean ratios >5 or >10 (dashed lines).
(C) Isolated mitochondria from HEK293T cells
expressing C12ORF62FLAG were treated with
thiamphenicol (TAP) (50 mg/mL) for 24 hr where
indicated and subjected to FLAG-immunoprecipi-
tation. Total, 3%; eluates, 100%.
(D) FLAG-immunoprecipitation experiments were
performed from isolated mitochondria purified
from HEK293T cells expressing FLAG tagged
mL62, C12ORF62, MITRAC12, MITRAC15, or
MITRAC7. Total, 3%; eluates, 100%.
See also Figure S1 and Table S1.lead to the central open question as to how mitochondrial trans-
lation can be adjusted to provide sufficient amounts of mito-
chondrial-encoded proteins to match the demands of OXPHOS
biogenesis.
The available information on the early steps of cytochrome c
oxidase biogenesis provides us with a unique opportunity to
assess mitochondrial translation in the context of assembly be-
tween mitochondrial- and nuclear-encoded subunits. Here, we
demonstrate that a ribosome nascent chain complex selectively
translating COX1 mRNA associates with early assembly factors
of the cytochrome c oxidase. Translation of COX1 progresses
through defined membrane-integrated translation intermediates
that engage with assembly factors in the inner mitochondrial
membrane cotranslationally. Most importantly, our analyses
reveal translational plasticity in mitochondria. A block in early
steps of cytochrome c oxidase assembly stalls translation. The
concomitantly accumulated ribosome COX1 nascent chain
complex represents an assembly primed state of the translation
product. We propose that this mechanism of translational
plasticity enables a spatially precise control of translation that
eventually allows adaptation to the influx of imported subunits
according to cellular demands.472 Cell 167, 471–483, October 6, 2016RESULTS
Mitochondrial Ribosomes
Associate with the MITRAC
Assembly Intermediate
MITRAC represents a group of early as-
sembly intermediates of COX1 (Richter-
Dennerlein et al., 2015). C12ORF62 and
MITRAC12 are genuine constituents of
the MITRAC complexes, required for
cytochrome c oxidase assembly andtranslation of COX1. When mitochondrial translation products
are labeled with [35S]methionine prior to immunoisolation of
C12ORF62 or MITRAC12, both proteins are found in association
with newly synthesized full-length COX1 (Figure 1A). However, in
contrast to C12ORF62, MITRAC12 coisolated COX2, which is
recruited to COX1 after the first nuclear-encoded subunits
have engaged with COX1 (Mick et al., 2011; Soto et al., 2012).
This finding suggested that C12ORF62 and MITRAC12 are
bound to COX1 at different stages of the COX1 biogenesis
process and that C12ORF62 potentially acts earlier. To assess
the function of C12ORF62 in cytochrome c oxidase assembly
and translation, we determined its interaction network. We
generated a stable HEK293T cell line utilizing a genomically
integrated C12ORF62FLAG-encoding cassette enabling expres-
sion of the tagged protein at physiological level (Figure 1C).
C12ORF62FLAG-containing complexes were purified after stable
isotope labeling with amino acids in cell culture (SILAC) and cop-
urified proteins identified by quantitative mass spectrometry. As
expected, we recovered the known constituents of MITRAC and
early assembling structural subunits of complex IV. Unexpect-
edly, the large and small subunits of the mitochondrial ribosome
copurified with C12ORF62 and were detected with a subunit
Figure 2. C12ORF62-Associated Mitochondrial Ribosomes Are Committed to COX1 Synthesis
(A–C) Immunoprecipitation from indicated cell lines was performed as in Figure 1D. Isolated RNA samples of total and eluates were quantified by real-time PCR (A)
and NanoString technology (B and C). Levels of copurified RNA were calculated relative to mL62 (A) or total (B and C), respectively (mean ± SEM; n = 3).coverage of 91% (Amunts et al., 2015; Greber et al., 2015) (Fig-
ure 1B; Table S1). We confirmed ribosome association to
C12ORF62 by western blot analyses (Figure 1C). Interestingly,
when cells were treatedwith the translational inhibitor, thiamphe-
nicol, prior to isolation, the ribosome-C12ORF62 associationwas
lostwhileMITRACcomplex constituents, including thepreviously
synthesized COX1 and the mitochondrial export protein OXA1L,
remained associated. This suggested that only translating ribo-
somes engage with C12ORF62, while the interaction with the
OXA1L insertase was maintained in the absence of ribosome as-
sociation (Figure 1C). Based on this, we assessed whether ribo-
some association was specific to C12ORF62 or common to
COX1-associated assembly factors. In immunoprecipitation ana-
lyses, MITRAC12 and also MITRAC15, which is required for
complex IVaswell as complex I biogenesis (Micket al., 2012), dis-
played ribosome-association, but to a lesser extent than
C12ORF62. In contrast, the late-acting MITRAC7 displayed
COX1- and MITRAC-association, but no ribosome interactions
(Figure 1D).Weconcluded thatCOX1assembly factors associate
with translating ribosomes in early stepsof theassemblyprocess.
Mitochondrial Ribosomes Associated with C12ORF62
Translate COX1 mRNA
Because C12ORF62 interacted specifically with translating ribo-
somes, we hypothesized that the MITRAC-associated ribo-somes were selectively dedicated to translation of COX1. To
assess this directly, we first analyzed the level of COX1 mRNAs
that copurified with early and late MITRAC components using
real-time PCR. In agreement with our hypothesis, C12ORF62-
associated ribosomes contained significant levels of COX1
mRNA and only negligible amounts of COX2 transcript
(Figure 2A). To further support and extend this finding by
quantitative data, we assessed RNAs that were bound to
C12ORF62-associated ribosomes by NanoString analysis. The
recovery of 12S and 16S rRNA supported the ribosome isolation
shown by western blot analysis (Figure 1D) as both RNAs specif-
ically copurified with C12ORF62 and MITRAC12. Moreover,
COX1 mRNA was mainly isolated with C12ORF62 and to a
lesser extent with MITRAC12 (Figure 2B). Other mitochondrial-
encoded transcripts were only negligibly recovered with
C12ORF62. In contrast, when ribosomes were isolated via
mL62 (ICT1), a core component of the mitochondrial ribosome
(Richter et al., 2010), all tested mitochondrial transcripts copuri-
fied (Figure 2C).
In yeast mitochondria, mRNAs possess 50UTRs that are
recognized by specific translational activators, which are essen-
tial to facilitate translation (Herrmann et al., 2013). In humanmito-
chondria, 50UTRs and translational activator proteins are not
conserved, indicating that different mechanisms for translational
regulation have to be in place (Ha¨llberg and Larsson, 2014;Cell 167, 471–483, October 6, 2016 473
Figure 3. C12ORF62 Associates with COX1
during Synthesis
(A and B) [35S]methionine-labeled mitochondrial
translation products from 143B wild-type (WT) and
COX1G6930A mutant (G6930A) cell lines were sub-
jected to immunoisolation using indicated anti-
bodies. Total, 5%; eluates, 100%.
(C and D) HEK293T cells were incubated in
[35S]methionine-containing medium for 30 min and
treated with puromycin (Pur) (2 mg/mL) where
indicated for 10 or 20 min. Cell lysates were sub-
jected to C12ORF62 immunoisolation. Total, 5%;
eluates, 100%. COX1 fragments (COX1f1–f3), indi-
cated by asterisks, were quantified in (D) (mean ±
SEM; n = 3).
(E) HEK293T cells were labeled and treated as
in (C). Puromycin was added for 20 min
where indicated prior to immunoisolation using
C12ORF62 and MITRAC12 antibodies. Samples
were analyzed as in (C).
(F and G) Experiments were performed as in (C).
Radiolabeled samples were subjected to im-
munoisolation using antibodies against MITRAC7
(F) and TIM21 (G), in comparison to C12ORF62.
See also Figure S2.Herrmann et al., 2013; Soto et al., 2012). Based on the observed
association between ribosomes and early assembly intermedi-
ates in human mitochondria, we tested whether Cox14 and
Coa3, early assembly factors of Cox1 (Barrientos et al., 2004;
Fontanesi et al., 2011; Mick et al., 2011), similarly associated
with ribosomes in yeast. Both Cox14 and Coa3 copurified
each other and Cox1. However, our analyses did not reveal evi-
dence for an interaction between these assembly factors and
mitochondrial ribosomes (Figure S1). In contrast, mitochondrial
ribosome copurified efficiently with Mba1, a ribosome receptor
in yeast mitochondria (Ott et al., 2006). In summary, in human
mitochondria, early COX1 assembly factors engage with mito-
chondrial ribosomes selectively translating COX1 mRNA. We
conclude that, among the known assembly factors, C12ORF62
represents the major ribosome-interacting constituent of the
MITRAC complex.474 Cell 167, 471–483, October 6, 2016Distinct COX1 Translation
Intermediates Associate with
C12ORF62
COX1 consists of 12 transmembrane
spans (TM) exposing both termini into
the mitochondrial matrix (Tsukihara
et al., 1996). To test whether C12ORF62
required a full-length COX1-protein for
association, we [35S]methionine pulse-
labeled mitochondrial translation prod-
ucts in a cell line carrying a G to A
transition in COX1 (G6930A). This muta-
tion generates a ‘‘hungry codon’’ that
leads to expression of a main translation
product truncated after leucine 342 within
the ninth membrane span (COX11–342)
(D’Aurelio et al., 2001; Temperley et al.,2010) and minute amounts of full-length COX1 (Figure 3A).
Despite the lack of its C-terminal portion, COX11–342 copurified
efficiently with C12ORF62 (Figure 3A). Similarly, the 35S-labeled
COX11–342 could be coimmunoprecipitated with MITRAC12 and
MITRAC7, indicating that the truncated protein enters into early
cytochrome c oxidase assembly intermediates (Figure 3B).
The observed interactions of C12ORF62 with ribosomes (Fig-
ure 1) and with the truncated translation-product of COX1 sug-
gested to us that C12ORF62 might associate with nascent
COX1. To test this directly, we treated mitochondria during
pulse-labeling with puromycin to release nascent chains from
mitochondrial ribosomes. Instead of an array of translation
products, COX1 (fully translated during pulse) and three
distinct shorter translation products (COX1f1–f3) copurified with
C12ORF62 (Figure 3C and quantification in Figure 3D). These
three translation products also associated with MITRAC12
(Figure 3E). However, we were unable to recover COX1f1–f3 in im-
munoprecipitations of the later-acting MITRAC7 or TIM21 (Fig-
ures 3F, 3G, S2A, and S2B). In contrast, in yeast mitochondria
nascent Cox1 did not copurify with the early assembly factor
Coa3 upon puromycin treatment (Figure S2C), which is in agree-
ment with the absence of an interaction between Coa3 andmito-
chondrial ribosomes. In summary, our findings suggest that the
early assembly factors, C12ORF62 and MITRAC12, interact
with nascent COX1, whereas components of a late MITRAC
only associate with the full-length COX1.
Defining Ribosome Nascent Chain Complexes of COX1
Due to its hydrophobicity, COX1 displays aberrant migration on
SDS-PAGE. Hence, we estimated the length of the largest
truncated translation product by comparing its migration to
COX11–342. COX1f3 migrated slightly faster than COX11–342, indi-
cating that translation was terminated upstream of transmem-
brane span (TM) 9 (Figures 4A and 4C). This was supported
by the observation that upon puromycin treatment of the
COX1G6930A cell line, the same truncated COX1 products copuri-
fied with C12ORF62 as in the wild-type control (Figure 4B). We
concluded that C12ORF62 interacted with N-terminal fragments
of COX1 that contain less than nine TM helices.
To define the lengths of the truncated translation products with
a molecular ruler, we synthesized a recoded COX1 gene and ex-
pressed defined COX1 fragments (Figure 4C) in reticulocyte
lysate and compared their migration to the COX1 fragments
that interacted with C12ORF62 after puromycin treatment (Fig-
ure 4D). We estimated that COX1f3 represented a fragment of
280 amino acid (aa), COX1f2 ended after 212 aa, and
COX1f1 was even slightly shorter (Figure 4D). Taking the topol-
ogy of COX1 into consideration and the fact that 30–60 aa
are covered by the ribosomal exit tunnel (Kramer et al., 2009),
C12ORF62 appears to recruit ribosome nascent chain com-
plexes when helices 1–4 or 1–6 are translated and membrane in-
serted. Accordingly, COX1 translation occurs in a discontinuous
manner. Three major translation products, which are partially
membrane-inserted, are generated (Figure 4E). Moreover, these
nascent COX1 chains associate with C12ORF62 in a cotransla-
tional manner. Our results are in agreement with previous find-
ings by Rooijers et al. (2013) using ribosome profiling to show
thatmitochondrial ribosomes are not equally distributed onmito-
chondrial transcripts. These data suggest hotspots for ribosome
pausing, which agrees with an accumulation of distinct COX1
fragments when released with puromycin.
C12ORF62 and MITRAC12 Act Consecutively
Our analyses showed that both C12ORF62 and MITRAC12
engage with ribosome-nascent chain complexes translating
COX1. However, they apparently associate to a different extent
(see above). To assess the functional interplay of the two
proteins in COX1 translation, we depleted C12ORF62 by small
interfering RNA (siRNA)-mediated knockdown (Figure 5A).
C12ORF62-deficient cells displayed a severe growth defect
compared to the non-targeting control that could be overcome
by expression of a siRNA-resistant version of C12ORF62FLAG
(scC12ORF62FLAG) (Figure 5B), demonstrating specificity of
used siRNA and functionality of FLAG-tagged C12ORF62.When we pulse-labeled mitochondrial translation products with
[35S]methionine, a drastic reduction in the amount of COX1
was apparent (Figure 5C). The phenotype observed here agreed
with previous analyses on the loss of C12ORF62 (Mick et al.,
2012; Weraarpachai et al., 2012). Because COX1 is a target of
them-AAA protease (Hornig-Do et al., 2012), we tested whether
the decreased level of newly synthesized COX1 was a result of
an increased turnover by the quality control machinery. To this
end, we downregulated the m-AAA protease subunit AFG3L2
together with C12ORF62 (Figure S3A). However, when AFG3L2
was depleted, we did not observe a significant increase in the
amount of newly synthesized COX1. Accordingly, the decreased
level of newly synthesized COX1 observed upon C12ORF62
knockdown is apparently not a result of increased turnover but
rather of reduced translation. Interestingly, compared to cells
depleted for MITRAC12 (Figure S3B), the amount of COX1 syn-
thesized in 1 hr in the C12ORF62 knockdown was clearly exac-
erbated suggesting that COX1 synthesis was more sensitive to a
loss of C12ORF62 (Figures 5D andS3C). To further ascertain that
the observed reduction in COX1 reflected a reduced synthesis
rather than an increased turnover, we followed the fate of newly
synthesized COX1 in a chase experiment over time. While COX1
displayed a half-life of 24 hr upon MITRAC12 knockdown (Mick
et al., 2012), in C12ORF62-deficient cells, turnover of COX1
was indistinguishable from the non-targeting control (Figures
5E and S3D). Accordingly, the reduction in the amount of
COX1 observed during pulse labeling cannot be reconciled
with the half-life of the protein but rather reflects a reduction in
translation.
Our results were in agreement with the idea that C12ORF62
acted upstream of MITRAC12 in COX1 biogenesis. To assess
directly whether the translation intermediates of COX1 associ-
ated with MITRAC12 or C12ORF62 were present in the same
protein complex, we released COX1f1–f3 from ribosomes with
puromycin, isolatedMITRAC12, or C12ORF62 under native con-
ditions, and analyzed the purified complexes by BN-PAGE
(Figure 5F). Both proteins purified theMITRAC intermediate con-
taining full-length COX1 (Dennerlein et al., 2015; Mick et al.,
2012). In addition, both proteins purified a faster migrating pro-
tein complex (MITRACPre2). However, an even smaller complex
(MITRACPre1) was unique to the C12ORF62 purified sample (Fig-
ure 5F). We conclude that the COX1 translation intermediates
initially associate with C12ORF62, and MITRAC12 is recruited
sequentially. To assess whether the COX1 nascent chain inter-
mediates could be retrieved for further COX1 synthesis, we per-
formed [35S]methionine-labeling pulse chase analyses and
determined the level of nascent and full-length COX1 isolated
with MITRAC12FLAG (Figure 5G). As expected, the COX1f1-3
nascent chains decreased during chase, while full-length
COX1 increased in a time-dependent manner. Hence, COX1
nascent chain intermediates can mature to full-length COX1
and thus represent productive translation intermediates.
Association of COX4 toNewly SynthesizedCOX1Occurs
Posttranslationally
During the assembly process of the cytochrome coxidase, COX4
(yeast Cox5, see Table S2) is the first nuclear-encoded subunit
that associates with newly synthesized COX1. Subsequently,Cell 167, 471–483, October 6, 2016 475
Figure 4. Membrane Topology and Interactions of COX1 Fragments
(A and B) Mitochondrial translation products were labeled with [35S]methionine in 143Bwild-type (WT) and COX1G6930Amutant cells, treated with puromycin (Pur)
(2 mg/mL) where indicated and subjected to C12ORF62 immunoprecipitation. Total, 5%; eluates, 100%. Asterisks and a red arrowhead indicate puromycin-
released COX1 fragments COX1f1–f3 and mutant COX11–342, respectively.
(C) Schematic presentation of COX1 topology. The position of premature stop codons for in vitro COX1 synthesis, as in (D), are indicated by arrowheads. Relative
position of mutation of COX1G6930A in transmembrane domain nine is indicated by a red arrow. N, amino-terminal; C, C-terminal; IMS, intermembrane space;
IMM, inner mitochondrial membrane.
(legend continued on next page)
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Figure 5. C12ORF62 Acts as the Initial COX1 Maturation Protein
(A and B) Depletion efficiency and specificity of C12ORF62 siRNA-mediated downregulation. HEK293T cells were treated with siRNA oligonucleotides against
C12orf62 or with control siRNA for 72 hr followed by western blot analysis (A). Expression of a siC12orf62-1-resistant form of FLAG tagged C12ORF62 restores
the growth phenotype upon loss of endogenous C12ORF62. Cells inducibly expressing scC12ORF62FLAGwere treatedwith siC12orf62-1 for 72 hr in the presence
of tetracycline (Tet) where indicated. Dashed line represents the starting cell number (mean ± SEM, n = 6) (B).
(C–E) COX1 synthesis and stability in C12ORF62-deficient cells. C12ORF62 was depleted from HEK293T cells for 72 hr followed by radiolabeling for 1 hr (C).
Levels of newly synthesized COX1 were quantified, internally standardized to ATP6, and normalized to non-targeting control (dashed line) in C12ORF62- and
MITRAC12-deficient cells (mean ± SEM, n = 3) (D). COX1 stability was determined after 24 hr chase (mean ± SEM, n = 3) (E).
(F) FLAG immunoisolation of C12ORF62 and MITRAC12. HEK293T cells were [35S]methionine labeled, treated with puromycin (Pur) where indicated, and
subjected to immunoprecipitation. Protein complexes were natively eluted and analyzed by SDS-PAGE (left panel) and BN-PAGE (right panel). COX1 fragments
are indicated by asterisks and pre-complexes of MITRAC are labeled with MITRACPre1 and MITRACPre2 (# undefined complex).
(G) COX1 translation intermediates can be retrieved for translation. HEK293T cells were incubated with [35S]methionine and chased after media replacement for
indicated time points with cold methionine. All samples were treated with puromycin for 20 min prior to MITRAC12FLAG immunoisolations (left panel). COX1
fragments and full-length COX1 isolated by MITRAC12FLAG were quantified (mean ± SEM, n = 4) (right panels).
See also Figure S3.COX5A (yeast Cox6) associates with COX1 and COX4 to form an
assembly intermediate prior to addition of the mitochondrial-en-
coded COX2 (Dennerlein and Rehling, 2015; Fontanesi, 2013;
Soto et al., 2012). In the mature cytochrome c oxidase, COX4
bridges TM1 and TM12 of COX1, but also contacts COX1 with
its matrix and intermembrane space domains (Figures 6A and
S4). At steady state, the majority of COX4 resides in complex IV
and only a fraction is present in MITRAC assembly intermediates
(Figure 6B). Upon puromycin treatment, import of [35S]COX4 into(D) HEK293T cells, 143B wild-type (WT) and the COX1G6930A mutant were treated
number of amino acids) were synthesized and radiolabeled in vitro using rabbit re
asterisks and aligned with in vitro synthesized COX1 peptides (asterisk). Mutant
(E) Schematic presentation of discontinuously synthesized fragments in relationmitochondria and subsequent purification of MITRAC12 or
C12ORF62, we did not recover COX4 in MITRACPre1 or MI-
TRACPre2 (Figure 6C). This finding suggested that COX4 only
associated with full-length COX1, which agreed well with the
available structural data.
Remarkably, we found that readily detectable amounts of
mitochondrial ribosomes copurified with COX4, indicating that
ribosomes are engaged with MITRAC complexes at the stage
of COX4 assembly to COX1 (Figure 6D).and radiolabeled as in (A). COX1 peptides of defined lengths (indicated by the
ticulocyte lysates. Puromycin (Pur)-released COX1 fragments are indicated by
COX11–342 protein in the COXG6930A cell line is marked by red arrowheads.
to COX1 membrane topology.
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Figure 6. COX4 Interacts with Premature
COX1
(A) Structure of COX1 and COX4 in the mature
bovine complex IV. PDB: 3ASN; COX4, red; COX1,
green with TM1, blue; TM12, orange (Suga et al.,
2011).
(B) Two-dimensional BN/SDS-PAGE analysis of
COX4. RCS, respiratory chain supercomplexes; IV,
complex IV.
(C) HEK293T cells were treated with puromycin
(Pur) for 20 min where indicated. Mitochondria
were isolated and [35S]methionine-labeled COX4
was imported for 45 min. Samples were subjected
to FLAG immunoprecipitation followed by BN-
PAGE (upper panel) and SDS-PAGE (lower panel)
analyses.
(D) Isolated mitochondria from HEK293T cells ex-
pressing COX4FLAG were subjected to FLAG-
immunoprecipitation. Total, 1%; eluates, 100%.
(E) Mitochondrial translation products were radio-
labeled in HEK293T cells. Cell lysates were
subjected to immunoisolation using indicated
antibodies. Mitochondrial translation was termi-
nated with puromycin (Pur) prior to isolation where
indicated. #, undefined mitochondrial translation
product. Total, 5%; eluates, 100%.
(F) Mitochondrial translation products were labeled
with [35S]methionine in 143B wild-type (WT) and
COX1G6930Amutant cells. Samples were subjected
to immunoisolation and analyzed as in (E). Total,
5%; eluates, 100%.
See also Figure S4.This finding led us to assess whether the first nuclear-
encoded structural subunit associated with COX1 cotransla-
tionally. To this end, we tested the interaction of COX4 with
nascent COX1f1–f3 by immunoisolation of COX4 after [35S]methi-
onine-labeling. While COX4 copurified full-length COX1, the
nascent translation products COX1f1–f3 were not found (Fig-
ure 6E). Surprisingly, when COX4 was isolated from COX1G6930A
cells, the fully synthesized shortened version COX11–342 was
found in complex with COX4 (Figure 6F). This finding demon-
strates that TM10–TM12 were dispensable for the initial binding
of COX4 to COX1. Despite ribosome association with COX4-
containing MITRAC intermediates, COX4 only binds to COX1
upon completion of its synthesis. We conclude, that association
of the first nuclear-encoded cytochrome c oxidase subunit,
COX4, to COX1 occurs posttranslationally. However, a full-478 Cell 167, 471–483, October 6, 2016length COX1 molecule is not required
for an interaction with COX4.
Defects in COX1 Assembly Cause
Accumulation of a Ribosome
Nascent Chain Complex
In contrast to COX4, C12ORF62, and
MITRAC12 engage with COX1 cotransla-
tionally. A stabilizing function for full-
length COX1 has been attributed to
MITRAC12, which remains COX1-associ-
ated beyond the stage of COX4 assembly(Clemente et al., 2013; Dennerlein et al., 2015; Mick et al., 2012;
Ostergaard et al., 2015). At the same time, loss of C12ORF62 or
MITRAC12 affects COX1 translation (Figure 5D) (Mick et al.,
2012; Ostergaard et al., 2015; Weraarpachai et al., 2012). These
observations led us to hypothesize that mitochondrial translation
could be coupled to the formation of COX1-containing biogen-
esis intermediates. Therefore, we assessed whether ribosome
performance was affected when the assembly process was
compromised. To this end, we immunoisolated C12ORF62 after
pulse-labeling of mitochondrial translation products under
conditions of siRNA-mediated knockdown of MITRAC12.
MITRAC12 depletion specifically led to accumulation of ribo-
some nascent chain complex containing the COX1f1–f3 frag-
ments in a C12ORF62-associated state (Figure 7A and quantifi-
cation in Figure 7B). This finding was in agreement with the idea
Figure 7. Nascent Chain Ribosome Com-
plexes Accumulate on Early Assembly Fac-
tors upon Block of Complex IV Assembly
(A and B) MITRAC12 was depleted in HEK293T
cells by siRNA treatment for 72 hr prior to
[35S]methionine labeling and immunoisolation us-
ing antibodies as indicated (A). COX1 fragments
are labeled by asterisks. Total, 5%; eluates, 100%.
(B) Quantification of COX1 fragments upon
MITRAC12 depletion (mean ± SEM; n = 3).
(C) Cell lysates (50 mg for MITRAC12, C12ORF62,
SDHA, and TIM44; 25 mg for all other proteins) were
analyzed by SDS-PAGE and western blotting.
Quantification of COX4, COX1, and C12ORF62
protein levels (mean ± SEM, n = 4) after 72 hr
knock-down of COX4.
(D) Quantification of newly synthesized COX1 upon
COX5B and COX4 depletion. Level of COX1
synthesis (standardized to ATP6) were calculated
and normalized to non-targeting control (mean ±
SEM; n = 3).
(E) COX4 was ablated in HEK293T cells prior to
radiolabeling of mitochondrial translation prod-
ucts. Samples were subjected to immunoprecipi-
tation using indicated antibodies. Radiolabeled
protein bands were quantified along the gel lanes
and the differential profile (Dintensity) plotted along
the gel section of interest. Bottom graph, increase
of COX1f1/f2 fragments relative to the control
(mean ± SEM; n = 4).
(F) COX4 and MITRAC12 were depleted in
HEK293T cells expressing C12ORF62FLAG by
siRNA treatment for 72 hr prior to [35S]methionine
labeling and FLAG-immunoisolation. Upper panel:
western blot analysis of cell lysates. Lower panel:
BN-PAGE analysis of natively eluted im-
munoisolation samples. As a control, one sample
was treated with puromycin prior to isolation
omitting siRNA treatment.
See also Figure S5.of a link between the COX1 assembly process andmitochondrial
ribosome function.
To analyze whether mitochondrial ribosomes display transla-
tional plasticity to adapt translation in response to the availability
of nuclear-encoded subunits, we depleted COX4 by siRNA.
Western blot analyses of cell lysates demonstrated efficient
COX4 depletion. In addition, the level of COX1 was decreased
leading to the loss of functional complex IV (Figures 7C and
S5A). Obviously, this steady-state analysis did not discriminate
between the synthesis and turnover of COX1 under conditions
of COX4 depletion. Therefore, we assessed translation of COX1
by radiolabeling ofmitochondrial translation products under con-ditions of siRNA-mediated downregula-
tion of the early assembling COX4 and as
a control the later assembling COX5B
(yeast Cox4). While depletion of COX5B
had little effect on COX1 translation, a
depletion of COX4 noticeably reduced
COX1 synthesis (Figure 7D). To assess
directly whether the reduced synthesis ofCOX1 correlated with the formation of the COX1 ribosome
nascent chain complex, we immunoisolated C12ORF62 after ra-
diolabeling of translation products inCOX4-deficient cells. As ex-
pected, ablation of COX4 stalled COX1 translation and led to
accumulation of the nascent COX1 fragments in a C12ORF62-
bound state (Figure 7E). In contrast, ablation of COX6C (yeast
Cox9), a late assembling nuclear-encoded structural subunit,
and loss of the assembly factors SCO2 or SURF1, which partici-
pate in copper- and heme-insertion respectively, did not lead to
an accumulation of nascent COX1 associated with C12ORF62
(Figures S5B–S5D). We concluded that only the first steps in
the COX assembly process impact translational plasticity.Cell 167, 471–483, October 6, 2016 479
To address whether COX4 was required for the formation of
MITRACPre complexes, we depleted COX4 and isolated COX1-
intermediates via C12ORF62FLAG after [35S]methionine labeling
(Figure 7F). Interestingly, COX4 depletion led to accumulation
of MITRACPre1 and a concomitant loss ofMITRACPre2. Similar re-
sults were obtained when MITRAC12 was downregulated.
Hence, loss of COX4 or MITRAC12 stalls nascent COX1 in asso-
ciation with C12ORF62 in the MITRACPre1 complex. In summary,
we find that upon loss of the nuclear-encoded COX4, translation
of COX1 is stalled in a ribosome-nascent chain complex,
together with C12ORF62. As a result, the amount of newly syn-
thesized full-length COX1 decreases demonstrating translational
plasticity in response to the presence or absence of the nuclear-
encoded structural subunit COX4.
DISCUSSION
Protein complexes of the mitochondrial oxidative phosphoryla-
tion system are built from subunits of dual genetic origin. A cen-
tral and unanswered question is whether regulatory mechanisms
exist that allow cells to control the supply and to avoid unproduc-
tive accumulation of nuclear- and mitochondrial-encoded sub-
units in mitochondria (Barrientos et al., 2002; Greber and Ban,
2016; Herrmann and Funes, 2005; Richter-Dennerlein et al.,
2015). Recent work showed that, in general, the transport of nu-
clear-encoded proteins into mitochondria is integrated into
metabolic and cell-cycle control pathways (Harbauer et al.,
2014a, 2014b; Opalinska and Meisinger, 2015). With regard to
the synthesis of mitochondrial-encoded proteins, micro RNAs
have recently been found to stimulate mitochondrial translation
during muscle differentiation (Zhang et al., 2014). However, it is
currently unknown whether and how translation in mitochondria
can be balanced against the influx of nuclear-encoded respira-
tory chain subunits. Here, we demonstrate that mitochondrial ri-
bosomes are not unrestrained protein production enzymes but
rather display translational plasticity to cope with an altered
requirement of mitochondrial-encoded subunits. Ribosomes
that are specifically dedicated for COX1 translation associate
with early MITRAC components, C12ORF62 and MITRAC12.
C12ORF62 acts upstream of MITRAC12 and associates with
COX1 in a ribosome nascent chain complex. It is interesting to
note that the conserved protein insertase OXA1L (Funes et al.,
2011) copurifies with C12ORF62. This association is also
observed under conditions of thiamphenicol treatment when
translation is blocked and ribosomes are lost from the complex.
It is tempting to speculate that in the inner membrane, a pool of
OXA1L molecules is dedicated to bind a specific ribosome,
translating a dedicated mRNA, and linking this translation pro-
cess to an assembly route. For this to occur, specific accessory
factors, in the case of COX1 the C12ORF62, would have to asso-
ciate with OXA1L to facilitate selectivity in the membrane inser-
tion of a single defined mitochondrial-encoded polypeptide
chain.
Our analyses demonstrate that a block in the assembly pro-
cess of the cytochrome c oxidase by depletion of the first nu-
clear-encoded subunit that engages with COX1 stalls translation
of COX1. The ribosome nascent chain complex maintains COX1
translation intermediates in a partially membrane integrated480 Cell 167, 471–483, October 6, 2016(RTM1–TM4) and C12ORF62-bound state. We show that this
ribosome-arrested pool of COX1 represents the assembly
primed state that can be released to continue for full translation
when COX1 is recruited into subsequent assembly steps. Inter-
estingly, C12ORF62 deficiency leads to decreased COX1 syn-
thesis, however, COX1 stability remains unaltered (shown here
and in Mick et al., 2012; Weraarpachai et al., 2012), suggesting
a direct effect of C12ORF62 on COX1 translation performance
by MITRAC-associated ribosomes. In contrast, ablation of
MITRAC12 has a milder effect on translation and causes
reduced stability of newly synthesized COX1. This finding is in
agreement with the idea that two pathways contribute to
balancing the amount of COX1. Ribosome translational plasticity
allows to regulate the supply of subunits for assembly in
response to early steps of the assembly pathway and proteolytic
quality control mechanisms act subsequently (Dennerlein et al.,
2015; Quiro´s et al., 2015). The observed interaction between
mitochondrial ribosomes and early assembly intermediates in
human mitochondria reveals a functional and physical link
between formation of stalled COX1 nascent chains attached
to the ribosome and the cytochrome c oxidase biogenesis
process.
Apparently, mitochondrial translational plasticity is not limited
to metazoa. A recent study by Couvillion et al. (2016) demon-
strated a synchronization of mitochondrial and cytosolic
translation processes in Saccharomyces cerevisiae. Upon
nutrient-induced stimulation of nuclear-encoded gene expres-
sion, translation of mitochondrial-encoded respiratory chain
subunits is enhanced. Interestingly, stimulation of mitochondrial
translation relies on protein import into mitochondria. This
finding indicates that a flux of molecules from the cytosol to
mitochondria triggers the increase in translation. In contrast to
human mitochondrial mRNAs, yeast mRNA possess long
50UTRs, which are bound by mRNA-specific translational acti-
vator proteins to promote their translation. In case of yeast,
Cox1, one of the translational activators is Mss51. Mss51
activity is regulated in a feedback cycle. Upon accumulation
of Cox1 assembly intermediates, Mss51 is recruited to the
newly synthesized Cox1 in complex with the assembly factors
Coa3 and Cox14. This recruitment and potentially additional
assembly factors inactivate Mss51 to stall translation of the
COX1 mRNA (for review see Dennerlein and Rehling, 2015;
Herrmann et al., 2013; Soto et al., 2012). Here, we find that un-
der our experimental conditions, the assembly factors Coa3 and
Cox14 do not bind to mitochondrial ribosomes. This is in
contrast to what we observed for MITRAC constituents in hu-
man. Accordingly, the mechanistic bases for translational
plasticity in yeast and human must be very different because
50UTRs and translational activators are not conserved. Our
finding of a direct physical link of the translation machinery
with assembly intermediates in human might provide some
insight as to why human mitochondrial mRNAs have lost signif-
icant 50UTRs and RNA-binding translation activators to regulate
protein expression.
The metazoan mechanism of translational plasticity iden-
tified here represents an elegant way to adapt mitochondrial
protein production to the cellular demands. In principle,
many different mechanisms have been identified to regulate
elongation of nascent polypeptide chains (Rodnina, 2016).
Given the limited genetic accessibility of mitochondria and
the fact that many basic aspects of mitochondrial translation
are still enigmatic, it will be a challenging task to assess how
processivity of the mitochondrial ribosome is modulated at
the molecular level.
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Rabbit polyclonal antibody to human COX6A This paper PRAB3283
Rabbit polyclonal antibody to human uL1m This paper PRAB4964
Mouse monoclonal antibody to human bL12m Abcam ab58334
Rabbit polyclonal antibody to human uL23m This paper PRAB1716
Rabbit polyclonal antibody to human uS15m Proteintech 17006-1
Rabbit polyclonal antibody to human mS40 Proteintech 16139-1
Mouse monoclonal antibody to human OXA1L Proteintech 66128-1
Rabbit polyclonal antibody to human MITRAC15 This paper PRAB4814
Mouse monoclonal antibody to FLAG tag Sigma Aldrich F3165; RRID: AB_259529
Mouse monoclonal antibody to human COX2 Abcam ab110258; RRID: AB_10887758
Rabbit polyclonal antibody to human TIM21 This paper PRAB3674
Rabbit polyclonal antibody to human COX4 This paper PRAB1522
Mouse monoclonal antibody to human SDHA Novex 459200
Rabbit polyclonal antibody to human Rieske This paper PRAB1512
Rabbit polyclonal antibody to human ATP5B This paper PRAB4826
Rabbit polyclonal antibody to human TIM44 Proteintech 13859-1
Rabbit polyclonal antibody to human NDUFB8 This paper PRAB3764
Rabbit polyclonal antibody to human TIM23 This paper PRAB1527
Rabbit polyclonal antibody to human COX5B Proteintech 11418-2
Rabbit polyclonal antibody to human SCO2 This paper PRAB4982
Rabbit polyclonal antibody to human COX6C This paper PRAB4949
Rabbit polyclonal antibody to human SURF1 This paper PRAB1528
Rabbit polyclonal antibody to yeast Mba1 This paper PRAB0263
Rabbit polyclonal antibody to yeast Coa3 This paper PRAB2046
Rabbit polyclonal antibody to yeast Cox14 This paper PRAB1544
Rabbit polyclonal antibody to yeast Cox1 This paper PRAB0372
Rabbit polyclonal antibody to yeast Mrp51 Green-Willms et al., 1998 N/A
Rabbit polyclonal antibody to yeast uL29m Gruschke et al., 2010 N/A
Rabbit polyclonal antibody to yeast Cox4 This paper PRAB0578
Rabbit polyclonal antibody to yeast Tim17 This paper PRAB0302
Rabbit polyclonal antibody to yeast Tom70 This paper PRAB3530
Chemicals, Peptides, and Recombinant Proteins
Anti-FLAG M2 Affinity Gel Sigma-Aldrich A2220
L-lysine:2HCl - 13C6; 15N2 Cambridge Isotope Lab 13L-177
L-arginine:HCl - U-13C6; U-15N4 Cambridge Isotope Lab 13C-450
Protein-A Sepharose CL-4B GE Healthcare 17-0963-03
[35S]methionine Hartmann Analytic SCM-01
Puromycin invivoGen Ant-pr-1
Emetine dihydrochloride hydrate Sigma-Aldrich 219282
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Anisomycin AppliChem A7650,0025
Hygromycin B Invitrogen 10687010
Lipofectamine RNAiMax Invitrogen 13778-150
GeneJuice Novagen 70967-3
Critical Commercial Assays
SensiMix Sybr Low-Rox Kit Bioline QT62-05
First Strand cDNA Synthesis kit ThermoFisher Scientific K1612
Rapid DNA Ligation Kit ThermoFisher Scientific K1422
mMESSAGE mMACHINE SP6 Transcription Kit Ambion AM1340
Flexi rabbit reticulocyte lysate system Promega L4540
Experimental Models: Cell Lines
Human osteosarcoma 143B cells D’Aurelio et al., 2001 N/A
HEK293-Flp-In T-Rex ThermoFisher Scientific R78007
HEK293-Flp-In T-Rex-C12ORF62FLAG This study N/A
HEK293-Flp-In T-Rex-COX4FLAG This study N/A
HEK293-Flp-In T-Rex-MITRAC7FLAG Dennerlein et al., 2015 N/A
HEK293-Flp-In T-Rex-MITRAC12FLAG Mick et al., 2012 N/A
HEK293-Flp-In T-Rex-MITRAC15FLAG Mick et al., 2012 N/A
HEK293-Flp-In T-Rex-mL62FLAG This study N/A
Experimental Models: Organisms/Strains
YPH499 -Mat a, ade2-101 his3-D200 leu2-D1 ura3-52
trp1-D63 lys2-801
Sikorski and Hieter, 1989 N/A
Mba1ProtA - Mat a, ade2-101 his3-D200 leu2-D1
ura3-52 trp1-D63 lys2-801; mba1::mba1-TEV-ProtA-
7HIS-HIS3MX6
Lorenzi et al., 2016 N/A
Recombinant DNA
pOG44 Flp-Recombinase Expression Vector ThermoFisher Scientific V600520
pcDNA5/FRT/TO ThermoFisher Scientific V6520-20
pX330-U6-Chimeric_BB-CBh-hSpCas9 Addgene 42230
pEGFP-N1 Clontech N/A
Sequence-Based Reagents
See Table S4 for primer sequences N/A N/A
Software and Algorithms
MaxQuant - version 1.5.1.0 Cox and Mann, 2008 http://www.coxdocs.org/doku.php?id=:maxquant:
start
ImageQuantTL 7.0 software GE Healthcare http://www.gelifesciences.com/webapp/wcs/stores/
servlet/catalog/en/GELifeSciences-de/products/
AlternativeProductStructure_16016/
ImageJ 1.47v NIH https://imagej.nih.gov/ij/notes.html
PyMOL DeLano et al., 2000 https://www.pymol.org/
CCP4Interface - version 7.0.015 Winn et al., 2011 http://www.ccp4.ac.uk/index.phpCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to, and will be fulfilled by the corresponding author Peter Rehling
(Peter.Rehling@medizin.uni-goettingen.de).Cell 167, 471–483.e1–e5, October 6, 2016 e2
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines and Culture Conditions
Human embryonic kidney cell lines (HEK293-Flp-In T-Rex; HEK293T), 143B wild-type, and 143B COX1G6930A (D’Aurelio et al., 2001)
were cultured in DMEM (Dulbecco’s modified eagle medium) supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM L-gluta-
mine and 50 mg/ ml uridine at 37C under 5% CO2 humidified atmosphere.
An inducible HEK293T cell line expressing C-terminal FLAG tagged C12ORF62, mL62 (ICT1) or COX4 were generated as
described (Mick et al., 2012). In brief, HEK293T cells were transfected with pOG44 and pcDNA5/FRT/TO containing the respective
FLAG construct using GeneJuice as transfection reagent. Selection was started two days after transfection using hygromycin B
(100 mg/ ml). After two weeks single clones were isolated.
Surf1/ HEK293T cell line was generated applying the CRISPR/Cas9 technology as previously described (Ran et al., 2013).
Briefly, oligonucleotides (Table S4) containing the guide sequences were annealed and ligated into the pX330 vector. HEK293T cells
were transfectedwith pX330-Surf1 andwith the pEGFP-N1 plasmid. After three days single cells expressingGFPwere sorted by flow
cytometry into 96 well plates. After colony expansion single colonies were screened by immunoblotting.
For SILAC experiments, cells were cultured for five passages in DMEM lacking arginine and lysine and supplemented with 10%
(v/v) dialyzed FBS, 600 mg/ l proline, 42 mg/ l arginine hydrochloride (13C6
15N4-arginine ‘‘heavy’’) and 146 mg/ l lysine hydrochloride
(13C6
15N2-lysine ‘‘heavy’’). Cell counts were performed using a Neubauer chamber.
Yeast Strains and Culture Conditions
S. cerevisiae strains derived from YPH499 were used in this study (Sikorski and Hieter, 1989). The Mba1ProtA expressing strain was
generated by genomic insertion of a HIS3MX6marker-containing cassette as described previously (Janke et al., 2004). Expression of
the fusion protein was confirmed by western blot analysis.
Yeast cells were grown in liquid media containing 1% yeast extract, 2% peptone and 3%glycerol at 30Cwith shaking. Isolation of
yeast mitochondria was performed as previously described (Meisinger et al., 2006). For this yeast cells were grown to anOD600 of 2 at
30C. After isolation of yeast mitochondria, the mitochondrial pellet was suspend in SEM buffer (250 mM saccharose, 1 mM EDTA
and 10 mMMOPS) at a concentration of 10 mg protein/ml. Mitochondria were then aliquoted and snap-frozen in liquid nitrogen and
store at 80C.
METHOD DETAILS
siRNA Transfection
HEK293T cells were transfected with siRNA oligonucleotides (8.25 to 33 nM final) (Eurogentec) using Lipofectamine RNAiMAX
(Invitrogen) following the reverse transfection protocol provided by the company. Cells were cultured for 72h prior analyses. Se-
quences for the sense strands of oligonucleotides are provided in Table S4.
In Vitro Protein Synthesis and Import Analysis
Cloning, RNA and protein synthesis were performed as previously described (Dennerlein et al., 2015). Briefly, cDNA was generated
from isolated RNA using First Strand cDNA Synthesis kit (Thermo Scientific). PCR amplicons were digested for 30 min at 37C using
Fast Digest Restriction enzymes (Thermo Scientific) and ligated into appropriate vectors using the Rapid DNA Ligation Kit (Thermo
Scientific).
Protein import into humanmitochondria isolated fromHEK293T cells was performed as described by Lazarou et al. (2009). In brief,
to generate radiolabeled precursor proteins, RNA was synthesized from PCR products, which were amplified from cDNA. Proteins
were synthesized in the presence of [35S]methionine using rabbit reticulocyte lysates (Promega) following the manufacture instruc-
tions. Radiolabelled proteins were incubated with freshly isolated mitochondria in import buffer (250 mM sucrose, 20 mM HEPES/
KOH [pH 7.4], 5 mM MgOAc, 15 mM sodium succinate, 15 mM malate, 3 mM ATP and 3 mM NADH) for 45 min, at 37C,
450 rpm. Mitochondria were pelleted at 10,000 3 g, washed in 150 ml SEM buffer (250 mM sucrose, 1 mM EDTA, 10 mM MOPS
[pH 7.2]) and solubilized for either immunoprecipitation or BN-PAGE analysis. After immunoprecipitation experiments eluates
were separated either by SDS- or BN-PAGE and analyzed by digital autoradiography using Phosphorimager Screens and Storm
820 scanner from GE Healthcare. For quantifications the ImageQuant TL software was used (GE Healthcare). To generate in vitro
truncated COX1 peptides, a premature stop codon (UAA) was inserted where indicated. Primers are listed in Table S4. Numbers
represent the length of the synthesized peptides. The genetic code was adjusted for expression on cytosolic ribosomes of rabbit.
In Vivo [35S]Methionine Labeling of Mitochondrial Translation Products
The labeling of mitochondrial-encoded peptides was performed in 25 cm2 flasks as previously described (Chomyn, 1996) with some
modifications. Cytosolic translation was inhibited with 100 mg/ml emetine or anisomycin. Mitochondrial-encoded proteins were syn-
thesized in the presence of 200 mCi/ml [35S]methionine for the indicated time intervals. Mitochondrial translation was inhibited in pulse
experiments using 2 mg/ml puromycin for 10 or 20 min where indicated prior to sample analyses. For chase experiments to measure
COX1 stability the media was replaced by standard growth media and cells were further cultured for indicated time points.e3 Cell 167, 471–483.e1–e5, October 6, 2016
Radioactive signals were detected using Phosphor Screens and a Storm 820 scanner from (GE Healthcare). Eluted COX1 fragments
were quantified in relation to full-length isolated COX1 and are presented relative to the control.
To measure the kinetic reduction of COX1 fragments and increase in full-length COX1 associated with MITRAC12, HEK293T-MI-
TRAC12FLAG cells were pulse-labeled (10 min) with [35S]methionine as described. The chase was performed with standard growth
media, supplemented with 200 ng/ml L-methionine. Cells were further cultured for indicated time points followed by puromycin treat-
ment for 20min. Cells were lysed and applied to immunoisolation. Eluted full-length COX1 andCOX1 fragments after chase (5, 10 and
20 min) were quantified in relation to isolated full-length COX1 or COX1 fragments, respectively after 10 min pulse (chase = 0).
Affinity Purification Procedures
Affinity purification experiments were performed as described (Dennerlein et al., 2015) with modifications. Briefly, isolated mitochon-
dria or whole cell extracts were suspended in lysis buffer (50mM Tris/HCl [pH 7.4]; 150mMNaCl; 20 mMMgCl2; 10% glycerol; 1 mM
PMSF and 1% digitonin) and incubated for 30 min at 4C prior to centrifugation at 16,000 3 g at 4C for 15 min. Supernatants were
incubated either with anti-FLAG M2 Affinity Gel (Sigma) or with specific or control antibodies conjugated to ProteinA-sepharose (GE
Healthcare) for 1h. After washing of the resin, proteins were eluted with FLAG peptides or by pH shift (0.1 M Glycin [pH 2.8]).
BN-PAGE
Standard protocols for BN-PAGEwere used as described previously (Mick et al., 2012). In brief, native protein complexes were sepa-
rated on 4%–14%BN-PAGE. Prior to the gel run, mitochondria or cells were solubilized in 1% digitonin-containing buffer (50mMTris
[pH 7.4], 150 mMNaCl, 10%Glycerol, 20 mMMgCl2, 1 mMPMSF) at a concentration of 1 mg/ml. Insoluble material was removed by
centrifugation (16,0003 g, 15min, at 4C). The supernatant wasmixedwith BN-loading buffer (0.5%Coomassie Brilliant Blue G-250,
50 mM 6-aminocaproic acid, 10 mM Bis-Tris/HCl [pH 7]) and subjected to BN-PAGE analysis.
RNA Isolation, Quantitative Real-Time PCR, and NanoString Analyses
RNA was isolated from cell extracts or elution fractions after performing FLAG affinity purification experiments using TRIzolR reagent
(Invitrogen), following the manufacturers instructions.
cDNA was synthesized using random hexamer primer with the First strand cDNA Synthesis kit from Thermo Scientific, following
manufactures instructions. Reactions for quantitative Real-Time (RT)-PCR analysis were prepared using the SensiMix SYBR Low-
Rox One Step kit (Bioline). Samples of each experiment were quantified in triplicate and compared to mL62FLAG eluates (cDNA of
mL62 eluates were used in a 1/10 dilution). Primer pairs are listed in Table S4.
NanoString measurements were performed by the Microarray and Deep-Sequencing Core Facility, University Medical Center
Go¨ttingen (UMG), following the instructions provided by NanoString Technologies. Data of elution fractions was normalized to the
input sample. Sequences of probes are listed in Table S3.
Mass Spectrometric Analyses
Equal amounts of mitochondria isolated from differentially SILAC-labeled HEK293T wild-type cells or cells expressing
C12ORF62FLAG were mixed followed by FLAG-immunoisolation (n = 4 including label switch). Purified proteins were separated on
a NuPAGE Novex 4%–12% Bis-Tris gradient gel (Thermo Fisher Scientific) and visualized with colloidal Coomassie Brilliant Blue
G-250 followed by cutting of gel lanes into 12 equal slices. Gel slices were destained, cysteine residues reduced and alkylated, pro-
teins in-gel digested using trypsin, and peptides prepared for LC-MS analysis as described previously (Schwarz et al., 2015). LC-MS
analyseswere performed on anOrbitrap Elite instrument (Thermo Fisher Scientific, Bremen, Germany) directly coupled to anUltiMate
3000 RSLCnano system (Thermo Scientific, Dreieich, Germany). Peptides were washed and preconcentrated for 5 min on a
C18 m-precolumn (Acclaim PepMap m-Precolumn Cartridge; 0.3 mm 3 5 mm, particle size 5 mm, Thermo Scientific) at a flow rate
of 30 ml/min using 0.1% trifluoroacetic acid. Peptides were separated on a C18 reversed-phase nano LC column (Acclaim PepMap
RSLC analytical column; 75 mm 3 50 cm; particle size 2 mm; pore size 100 A; Thermo Scientific) at a temperature of 40C using a
binary solvent system consisting of 4%DMSO in 0.1% formic acid (solvent A) and 50%methanol, 30%acetonitrile, and 4%DMSO in
0.1% formic acid (solvent B). For peptide elution, a 30 min linear gradient of 1%–65% solvent B followed by 65%–95% solvent B in
5 min was employed. The flow rate was 250 nl/min.
TheOrbitrap Elite wasweekly calibrated using standard compounds and operatedwith the following settings: acquisition of full MS
scans (m/z 370 to 1,700) in the orbitrap at a resolution of 120,000 (atm/z 400) with an automatic gain control (AGC) of 13 106 ions and
amaximum injection time of 200ms; collision-induced dissociation (CID) of up to 15 of themost intense precursor ions (chargeR +2)
in the linear ion trap applying a signal threshold of 2,500, an AGC of 53 103, a maximum injection time of 150 ms, a normalized colli-
sion energy of 35%, an activation q of 0.25, and an activation time of 10 ms. The dynamic exclusion time for previously fragmented
precursor ions was set to 45 s.
Mass Spectrometric Data Analysis
Mass spectrometric raw data were processed with MaxQuant (version 1.5.1.0) (Cox and Mann, 2008) and its integrated search en-
gine Andromeda (Cox et al., 2011). Data were searched using the organism-specific UniProt human protein database including pro-
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performed with the following parameters: tryptic specificity with a maximum of two missed cleavages; precursor mass tolerances of
20 ppm for the first and 4.5 ppm for the main search; fragment ion mass tolerance of 0.5 Da; oxidation of methionine and acetylation
of protein N-termini as variable, carbamidomethylation of cysteine as fixed modification; 13C6/
15N2-lysine (Lys8) and
13C6/
15N4-argi-
nine (Arg10) as heavy labeled amino acids; false discovery rate of < 1%on peptide and protein level. For protein identification, at least
one unique peptide with a minimum of six amino acids was required.
SILAC-based relative protein quantification, performed using MaxQuant default settings including ‘‘match between runs,’’ was
based on unique peptides and a minimum ratio count of one. Ratios, reported as C12ORF62/WT values (Extended Data Table
S1), were log10-transformed. The mean log10 ratio across all replicates was calculated for each protein and p values using a
one-sided Student’s t test were determined. Proteins with a SILAC ratioR 5 and a p value < 0.05 were considered to be specifically
associated with C12ORF62 complexes.
In Organello Labeling of Mitochondrial Translation Products and Isolation of Yeast Mitochondrial Proteins
Mitochondrial translation products were labeled for 25 min with 20 mM [35S]methionine at 30C as previously described (Mick et al.,
2010). Samples were treated with 0.1mMpuromycin for 15min at 30C. Per reaction, mitochondria weremixed with freshly prepared
translation buffer (900 mM Sorbitol, 225 mM KCl, 22.5 mM Kpi [pH 7.4], 30 mM Tris [pH 7.5], 4.5 mg/ml BSA, 6 mM ATP, 0.75 mM
GTP, 9 mM 2-Ketoglutarat, 12 mM Creatin Phosphate, 19 mM MgSO4, 7.5 mg/ml Cycloheximide, 0.15 mM amino acid mixture
without Methionine) containing 2.5 mg/ml of creatine kinase. Labeling reaction was started by addition of [35S]methionine. Prior to
coimmunoprecipitation, mitochondria were washed with SEM buffer (250 mM sucrose, 1 mM EDTA and 10 mM MOPS). To detect
radioactive signals, Storage Phosphor Screens (GE Healthcare) were used and images were digitized using a Storm820 scanner (GE
Healthcare).
Mba1ProtA isolation and immunoisolation of Coa3 and Cox14 were performed as described previously (Bareth et al., 2013). Briefly,
the mitochondrial fraction was solubilized in 1% digitonin buffer containing 150 mM NaCl, 50 mM Tris-HCl [pH 7.5], 10% glycerol,
2 mM phenylmethylsulfonyl fluoride (PMSF) and 20 mM MgCl2 for 30 min on ice. Samples were clarified by centrifugation at
20,000 3 g at 4C for 10 min and added to beads. Binding was carried out for 2 hr with shaking at 4C. Beads were washed with
washing buffer containing 0.3% digitonin. For the Mba1ProtA isolation, bound material was eluted by overnight cleavage at 4C
with 0.4mg/ml AcTEV (tobacco etch virus [TEV]) protease. For the Coa3 and Cox14 isolation elution was performedwith 0.1MGlycin
(pH 2.8). Eluates were subsequently analyzed by SDS-PAGE and western blotting.
Data and Structural Analysis
Autoradiograms were quantified using ImageQuantTL 7.0 software (GE Healthcare). Western blots were quantified with a LAS3000
imaging system and the ImageJ 1.47v software. For the cytochrome c oxidase structure the Protein Data Bank entry 3ASN und
PyMOL were used. The interaction between COX4 and COX1, residues with a maximal distance of 5 A˚ between both proteins
were identified using CCP4Interface (version 7.0.015). Selected residues were highlighted within the structure using PyMOL.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including exact value of n (number of independent experimental replications), the definition of center and
dispersion and precision measures (mean ± SEM) are reported in the figures and the figure legends. Mass spectrometric data are
judged to be statistically significant when p < 0.05 by one-sided Student’s t test.e5 Cell 167, 471–483.e1–e5, October 6, 2016
Supplemental Figures
Figure S1. Yeast Cox14 and Coa3 Assembly Factors Do Not Associate with Mitochondrial Ribosomes, Related to Figure 1
Mitochondria from wild-type (WT) and Mba1ProtA expressing strains were solubilized in digitonin buffer and protein complexes isolated via immunoisolation (IgG
chromatography or Cox14- or Coa3-specific antiserum). Eluates were separated by SDS-PAGE and analyzed by western-blotting. Total 1%, eluate 100%.
Figure S2. Late COX Biogenesis Factors Do Not Interact with Nascent Chain Fragments as well as Yeast Coa3, Related to Figure 3
(A and B) Longer exposures of experiments shown in Figures 3F and 3G.
(C) Yeast Coa3 does not interact with Cox1 nascent chain. [35S]methionine labeling of mitochondrial translation products was carried out in organello mito-
chondria. Mitochondrial translational products were labeled for 25 min. Samples were treated with 0.1 mM puromycin (Pur) for 15 min and mitochondria sol-
ubilized in digitonin buffer and subjected to immunoisolation using Coa3-specific antiserum. Samples were analyzed by SDS-PAGE and digital autoradiography
or western blot. Total 10%, eluate 100%.
Figure S3. Mitochondrial Translation Is Affected upon Reduction of C12ORF62 and MITRAC12, Related to Figure 5
(A) Downregulation of them-AAA protease does not restore COX1 levels. AFG3L2 was depleted by siRNA application for 72 hr and COX1 quantified after SDS-
PAGE and digital autoradiography (mean ± SEM; n = 3).
(B) Steady-state levels of mitochondrial proteins after siRNA-mediated downregulation of MITRAC12. HEK293T cells were treated with siRNAmolecules against
Mitrac12 for 72 hr followed by western blot analysis.
(C and D) COX1 synthesis and stability in C12ORF62- and MITRAC12-deficient cells. C12ORF62 and MITRAC12 were depleted from HEK293T cells for 72 hr
followed by radiolabeling for 1 hr. The cells were either harvested (C) or after media replacement, chased for indicated time points (D). Samples were analyzed by
SDS-PAGE and digital autoradiography.
Figure S4. Interaction Interface Map of COX4 to COX1 in the Mature Bovine Complex IV, Related to Figure 6
Highlighted are COX4 (red), COX1 TM2 and TM11 (green), COX1 TM1 (blue) and COX1 TM12 (orange). PDB: 3ASN (Suga et al., 2011).
Figure S5. Reduction of COX6C, SCO2, and SURF1 Does Not Lead to an Accumulation of Nascent Chain Ribosome Complexes, Related to
Figure 7
(A) Depletion of COX4 leads to cytochrome c oxidase deficiency. Isolated mitochondria from siRNAmediated COX4 ablated HEK293T cells (72 h) were subjected
to BN-PAGE and activity staining.
(B) Steady state of mitochondrial proteins after siRNA-mediated downregulation (72 h) of COX5B, COX6C, SCO2 and in Surf1/ cells.
(C) Mitochondrial protein synthesis in COX6C- and SCO2-depleted cells, and in Surf1/HEK293T cells. Mitochondrial translation products were radiolabeled for
1 hr in HEK293T cells treated with siRNAs against Cox6C and Sco2 (72 h) and in Surf1/ cells. Cells were harvested and samples analyzed by SDS-PAGE and
digital autoradiography.
(D) Nascent COX1 does not accumulate in a C12ORF62 complex upon loss of COX6C, SCO2 or SURF1. COX6C and SCO2 were ablated in HEK293T cells by
siRNA application for 72h prior to radiolabeling of mitochondrial translation products. Samples were subjected to immunoprecipitation using indicated antibodies
and eluates analyzed by SDS-PAGE and autoradiography. Total, 5%; eluates, 100%
